Bashkirian Republican Clinical Oncology Dispensary

Ufa, Bashkortostan Republic 450054

0 studies enrolling now · 2 studies all time

What they study most

Neoplasm Metastasis, Triple Negative Breast Cancer

Studies at this site

• A Safety Extension Study of Trastuzumab Emtansine in Participants Previously Treated With Trastuzumab Emtansine Alone or in Combination With Other Anti-Cancer Therapy in One of the Parent Studies — Running, not enrolling
• A Study Comparing Atezolizumab (Anti PD-L1 Antibody) In Combination With Adjuvant Anthracycline/Taxane-Based Chemotherapy Versus Chemotherapy Alone In Patients With Operable Triple-Negative Breast Cancer — Stopped early